Disease Detection

Infectious Disease Detection

< Back

SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit

Antigen Rapid Test Kit (LFIA)

Available for pre-order

Designed for rapid detection of SARS-CoV-2, Influenza A or B

About this kit

SARS-Cov-2 Influenza A/B Antigen Combo Rapid Test Kit (LFIA) is an immunochromatography based, one-step invitro test designed for the rapid qualitative determination of the above virus antigens in anterior nasal swabs from individuals suspected of COVID-19, Influenza A and Influenza B within the first seven days of symptom onset*. The test kit is designed for use as self-testing.

*Note that the combo rapid test kit shall not be used as sole basis to diagnose or exclude SARS-Cov-2 Influenza A/B infection.

Please contact us at sales@invitrovista.com for enquiries and immediate dispatch from Sweden.

Specifications

Test Principle

Colloidal Gold Immunochromatography

Specimen Type

Anterior Nasal Swab

Storage and Shelf Life

Storage away from direct sunlight, 2-30℃

Test kit must be used within 1 hour of opening foil pouch

Certificate

Disease Detection

Infectious Disease Detection

SARS-CoV-2 & Influenza A/B Antigen Combo Rapid Test Kit

Available for pre-order

Specifications

Colloidal Gold Immunochromatography

Anterior Nasal Swab

Storage away from direct sunlight, 2-30℃

Test kit must be used within 1 hour of opening foil pouch

CE IVD

Features

Convenience

Easily detect the presence of SARS-CoV-2, Influenza A or Influenza B antigens in one easy-to-use kit

Order Information

Medomics

1